T. Kitka

发表

Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivation

C. Adori, G. Bagdy, Z. Tóth, 2011, Neurochemistry International.

Small platform sleep deprivation selectively increases the average duration of rapid eye movement sleep episodes during sleep rebound

C. Adori, D. Pap, G. Bagdy, 2009, Behavioural Brain Research.

22nd European Congress on Obesity (ECO2015), Prague, Czech Republic, May 6-9, 2015: Abstracts

J. N. Fidalgo, Jimmy D Bell, L. S. Silveira, 2015, Obesity Facts.

Chronic escitalopram treatment attenuated the accelerated rapid eye movement sleep transitions after selective rapid eye movement sleep deprivation: a model-based analysis using Markov chains

G. Bagdy, L. Tothfalusi, T. Kitka, 2014, BMC Neuroscience.

Acute escitalopram treatment inhibits REM sleep rebound and activation of MCH-expressing neurons in the lateral hypothalamus after long term selective REM sleep deprivation

M. Palkovits, C. Adori, L. Kalmár, 2013, Psychopharmacology.

Efficacy of weight loss intervention can be predicted based on early alterations of fMRI food cue reactivity in the striatum

Z. Vidnyánszky, C. Kirwan, V. Gál, 2019, NeuroImage: Clinical.

Abundance and location of DARPP-32 in striato-tegmental circuits of domestic chicks

A. Csillag, G. Zachár, T. Kitka, 2004, Journal of Chemical Neuroanatomy.

Procognitive profiling of a serotonin 5-HT6 receptor antagonist in a complex model system in rats: A novel translational approach for clinical prediction

T. Kitka, I. Gyertyán, F. Kassai, 2020, Brain Research Bulletin.

Acute 5-HT2C Receptor Antagonist SB-242084 Treatment Affects EEG Gamma Band Activity Similarly to Chronic Escitalopram

G. Bagdy, P. Petschner, T. Kitka, 2020, Frontiers in Pharmacology.

MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition

G. Bagdy, S. Kantor, T. Kitka, 2008, Brain Research.

Effect of 5-HT2A/2B/2C receptor agonists and antagonists on sleep and waking in laboratory animals and humans

G. Bagdy, T. Kitka, 2008 .

Recent patents on novel MCH1 receptor antagonists as potential anti-obesity drugs.

T. Kitka, J. Éles, S. Farkas, 2014, Recent patents on CNS drug discovery.

Acute escitalopram treatment inhibits REM sleep rebound and activation of MCH-expressing neurons in the lateral hypothalamus after long term selective REM sleep deprivation

M. Palkovits, C. Adori, L. Kalmár, 2013, Psychopharmacology.

Small platform sleep deprivation selectively increases the average duration of rapid eye movement sleep episodes during sleep rebound

C. Adori, D. Pap, G. Bagdy, 2009, Behavioural Brain Research.